Loading chart…
PRE-MARKET
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products.
Abbott India Limited (ABBOTINDIA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ABBOTINDIA share price is ₹26,345.00 (-0.98% today), with a market capitalisation of ₹560B and a price-to-earnings (P/E) ratio of 34.7. MarketRipple tracks the ABBOTINDIA investment thesis, the ripple-chain impact of market events on Abbott India Limited, and the Healthcare sector outlook.
Open
₹26,615.00
High
₹27,065.00
Low
₹26,280.00
Prev. Close
₹26,605.00
52W High
₹30,655.00
52W Low
₹24,650.00
Day range
₹26,280.00–₹27,065.00
52-week range
₹24,650.00–₹30,655.00
Volume
16K
P/E
34.7
ROE
32.5%
D/E
0.04
Margin
23.1%
Abbott India Limited (NSE: ABBOTINDIA) is currently trading at ₹26,345.00 (-0.98%).
Abbott India Limited's market capitalization is ₹560B.
Abbott India Limited's price-to-earnings (P/E) ratio is 34.7.
Abbott India Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Abbott India Limited currently reads neutral, based on 8 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.